The New York Genome Center (NYGC) has appointed Cheryl Moore as president and COO. She will assume the position in January. Moore will be responsible for all business functions of NYGC, reporting to and partnering with Robert Darnell to set overall strategic direction and make key business decisions for the organizations.
Moore comes to NYGC after five years as the executive vice president and COO of the Howard Hughes Medical Institute, where she has led collaborative strategic efforts and oversees key operational functions. From 2004 to 2010, she served as COO of HHMI's Janelia Research Campus, where she was responsible for all operational aspects of the campus and its $100 million budget. Prior to HHMI, Moore served as senior vice president and COO of the Sanford Burnham Prebys Medical Discovery Institute.